RyR2 — Drug Target
All drugs that target RyR2 — marketed and clinical-stage. Includes 1 drug classes acting on this target.
Drug classes
Ryanodine receptor 2 inhibitor
Phase 2 pipeline (1)
- GSK256066 · GlaxoSmithKline · Ryanodine receptor 2 inhibitor · Cardiovascular
GSK256066 is a selective and potent inhibitor of the cardiac ryanodine receptor 2.